Embolization, Inc. says its novel radiopaque, polymer-based embolic coil has been implanted in more than 125 cases nationwide, indicating consistent performance across a range of use scenarios. The update is a positive product adoption milestone, but it is unlikely to move markets materially on its own.
Embolization, Inc. says its novel radiopaque, polymer-based embolic coil has been implanted in more than 125 cases nationwide, indicating consistent performance across a range of use scenarios. The update is a positive product adoption milestone, but it is unlikely to move markets materially on its own.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25